introduction: deep brain stimulation of the subthalamic nucleus (STN-DBS) can exert relevant effects on the voice of patients with parkinson's disease (PD). In this study, we used artificial intelligence to objectively analyze the voices of PD patients with STN-DBS. materials and methods: In a cross-sectional study, we enrolled 108 controls and 101 patients with PD. the cohort of PD was divided into two groups: the first group included 50 patients with STN-DBS, and the second group included 51 patients receiving the best medical treatment. the voices were clinically evaluated using the unified parkinson's disease rating scale part-III subitem for voice (UPDRS-III-v). we recorded and then analyzed voices using specific machine-learning algorithms. the likelihood ratio (LR) was also calculated as an objective measure for clinical-instrumental correlations. results: clinically, voice impairment was greater in STN-DBS patients than in those who received oral treatment. Using machine learning, we objectively and accurately distinguished between the voices of STN-DBS patients and those under oral treatments. we also found significant clinical-instrumental correlations since the greater the LRs, the higher the UPDRS-III-v scores. discussion: STN-DBS deteriorates speech in patients with PD, as objectively demonstrated by machine-learning voice analysis.
Suppa, A., Asci, F., Costantini, G., Bove, F., Piano, C., Pistoia, F., et al. (2023). Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis. FRONTIERS IN NEUROLOGY, 14, 1267360 [10.3389/fneur.2023.1267360].
Effects of deep brain stimulation of the subthalamic nucleus on patients with Parkinson's disease: a machine-learning voice analysis
Costantini G.;Bove F.;Cerroni R.;Cesarini V.;Pierantozzi M.;Pisani A.;Stefani A.;Saggio G.
2023-01-01
Abstract
introduction: deep brain stimulation of the subthalamic nucleus (STN-DBS) can exert relevant effects on the voice of patients with parkinson's disease (PD). In this study, we used artificial intelligence to objectively analyze the voices of PD patients with STN-DBS. materials and methods: In a cross-sectional study, we enrolled 108 controls and 101 patients with PD. the cohort of PD was divided into two groups: the first group included 50 patients with STN-DBS, and the second group included 51 patients receiving the best medical treatment. the voices were clinically evaluated using the unified parkinson's disease rating scale part-III subitem for voice (UPDRS-III-v). we recorded and then analyzed voices using specific machine-learning algorithms. the likelihood ratio (LR) was also calculated as an objective measure for clinical-instrumental correlations. results: clinically, voice impairment was greater in STN-DBS patients than in those who received oral treatment. Using machine learning, we objectively and accurately distinguished between the voices of STN-DBS patients and those under oral treatments. we also found significant clinical-instrumental correlations since the greater the LRs, the higher the UPDRS-III-v scores. discussion: STN-DBS deteriorates speech in patients with PD, as objectively demonstrated by machine-learning voice analysis.File | Dimensione | Formato | |
---|---|---|---|
voice fneur-14-1267360.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.12 MB
Formato
Adobe PDF
|
1.12 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.